What's Going On With Kintara Therapeutics Stock?
What's Going On With Kintara Therapeutics Stock?
Kintara Therapeutics, Inc. (NASDAQ:KTRA) shares are volatile Wednesday after the company announced it is seeking withdrawal of its registration statement for a public offering of securities.
週三，Kintara Therapeutics, Inc.（納斯達克股票代碼：KTRA）股價波動不定，此前該公司宣佈正在尋求撤回其證券公開發行註冊聲明。
The Details:
細節：
According to documents filed with the SEC, Kintara filed the registration withdrawal request on Wednesday for a registration statement on Form S-1 initially filed on Oct. 4, 2023.
根據 文件 Kintara於週三向美國證券交易委員會提交了註冊撤回申請，要求在最初於2023年10月4日提交的S-1表格上提交的註冊聲明。
Kintara shares are moving on heavy trading volume as inventors digest the SEC filing. According to data from Benzinga Pro, more than 100 million shares have already been traded in the session, compared to the stock's 100-day average of just over 10 million shares.
隨着發明家對美國證券交易委員會的文件進行消化，Kintara的股票交易量居高不下。根據Benzinga Pro的數據，該交易日已經交易了超過1億股股票，而該股的100天平均交易量剛剛超過1000萬股。
Related News: What's Going On With 'Bitcoin Developer' MicroStrategy Stock?
相關新聞： “比特幣開發者” 微策略股票怎麼了？
Should I Sell My KTRA Stock?
我應該賣出我的 KTRA 股票嗎？
When deciding to hold on to or sell a stock, investors should consider their time horizon, unrealized gains and total return.
在決定持有或出售股票時，投資者應考慮其時間範圍、未實現收益和總回報。
Shares of Kintara Therapeutics have decreased by 97.05% in the past year. An investor who bought shares of Kintara Therapeutics at the beginning of the year would take a loss of $0.06 per share if they sold it today. The stock has fallen 14.99% over the past month, meaning an investor who bought shares on Feb. 1 would see a capital loss of $0.03.
在過去的一年中，Kintara Therapeutics的股價下跌了97.05％。年初購買Kintara Therapeutics股票的投資者如果今天出售Kintara Therapeutics的股票，則每股虧損0.06美元。該股在過去一個月中下跌了14.99％，這意味着在2月1日購買股票的投資者將遭受0.03美元的資本損失。
Investors may also consider market dynamics. The Relative Strength Index can be used to indicate whether a stock is overbought or oversold. Kintara Therapeutics stock currently has an RSI of 23.07, indicating oversold conditions.
投資者也可以考慮市場動態。相對強弱指數可用於表明股票是超買還是超賣。Kintara Therapeutics股票目前的相對強弱指數爲23.07，這表明存在超賣情況。
For access to advanced charting and analysis tools and stock data, check out Benzinga PRO. Try it for free.
要訪問高級製圖和分析工具以及股票數據，請查看 Benzinga PRO。免費試用。
KTRA Price Action: According to Benzinga Pro, Kintara Therapeutics shares are up 13% at 9 cents at the time of publication.
KTRA價格走勢：根據Benzinga Pro的數據，Kintara Therapeutics的股價在發佈時上漲了13％，至9美分。
Image: Akava Photo from Pixabay
圖片：Akava 照片 來自 Pixabay